Giorgia Sulis

Contact Information

Giorgia Sulis, MD, PhD
+16135625800x8261
gsulis@ohri.ca

gsulis@uottawa.ca, https://sulislab.uottawa.ca

ORCID logo https://orcid.org/0000-0001-6641-0094

Giorgia Sulis

Associate Scientist, Methodological and Implementation Research
Ottawa Hospital Research Institute
Assistant Professor, School of Epidemiology and Public Health
University of Ottawa

Research Interests

1. Antibiotic prescribing and dispensing practices in primary care
2. Tuberculosis prevention
3. Vaccines and vaccination programs

Brief Biography

Dr. Giorgia Sulis is an Associate Scientist in the Methodological and Implementation Research Program at the Ottawa Hospital Research Institute and an Assistant Professor in the School of Epidemiology and Public Health at the University of Ottawa, where she holds a Tier 2 Canada Research Chair in Communicable Disease Epidemiology. Trained as a physician with specialization in infectious and tropical diseases in Italy, she completed a PhD and postdoctoral fellowship in epidemiology at McGill University. Her research program focuses on infectious disease epidemiology with an emphasis on antibiotic stewardship, tuberculosis prevention and care, vaccine uptake and impact, and best practices in global health research. She applies a range of quantitative and mixed-methods approaches to generate timely, policy-relevant evidence, particularly in resource-limited settings. Dr. Sulis has authored over 70 peer-reviewed publications and leads a multidisciplinary team engaged in national and international collaborations to advance equitable and evidence-informed public health solutions.

Selected Publications

  1. Akther A, Laurie C, Elton-Marshall T, Ly V, Sulis G. Healthcare workers' current practices, knowledge/awareness, barriers, and attitudes/perceptions related to pneumococcal vaccination of older adults: A mixed-methods systematic review. Vaccine. 2025 Jun 2;61:127331.
  2. Bigio J, Viscardi A, Gore G, Matteelli A, Sulis G. Risk of tuberculosis in individuals belonging to specific population groups: a scoping review. Eur Respir Rev. 2023 Jan 11; 32 (167):220127.
  3. Sulis G, Rodrigue V, Wolfson C, McMillan JM, Kirkland SA, Andrew MK, Basta NE. Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA). PLoS One. 2022 Oct 14;17(10):e0275923. 
  4. Sulis G, Tavaziva G, Gore G, Benedetti A, Solomons R, van Toorn R, Thee S, Day J, Verkuijl S, Brands A, Viney K, Masini T, Ahmad Khan F, Chiang SS. Comparative effectiveness of regimens for drug-susceptible tuberculous meningitis in children and adolescents: a systematic review and aggregate-level data meta-analysis. Open Forum Infect Dis. 2022 Jun;9(6): ofac108.
  5. Sulis G, Sayood S, Katukoori S, Bollam N, George I, Yaeger L, Chavez MA, Tetteh E, Yerrabelli S, Pulcini C, Harbarth S, Figueras A, Mertz D, Sharland M, Moja L, Huttner B, Gandra S. Exposure to WHO AWaRe antibiotics and isolation of multi-drug resistant bacteria: a systematic review and meta-analysis. Clin Microbiol Infect. Epub 2022 Mar 23.
  6. Sulis G, Batomen B, Kotwani A, Pai M, Gandra S. Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: an interrupted time series analysis. PloS Med 2021; 18(7):e1003682. 

Diseases, conditions and populations of interest





Research and clinical approaches